Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Substance Abuse : Research and Treatment
|
September 20, 2017
Moving on From Representativeness: Testing the Utility of the Global Drug Survey
Monica J Barratt, Jason A Ferris, Renee Zahnow, et al.
Drug and Alcohol Review
|
March 30, 2022
Who uses digital drugs? An international survey of 'binaural beat' consumers
Monica J Barratt, Alexia Maddox, Naomi Smith, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 6, 2023
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason A Ferris, Adam R Winstock, et al.
Drug and Alcohol Dependence
|
January 9, 2022
Exploring Televend, an innovative combination of cryptomarket and messaging app technologies for trading prohibited drugs
Monica J Barratt, Francois R Lamy, Liam Engel, et al.
International Journal of Public Health
|
April 2, 2018
Do people with intersecting identities report more high-risk alcohol use and lifetime substance use?
Daniel Demant, Oscar Oviedo-Trespalacios, Julie-Anne Carroll, et al.
Psychopharmacology
|
September 17, 2021
Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
Sam Craft, Jason A Ferris, Monica J Barratt, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 8, 2022
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
Emma I Kopra, Jason A Ferris, James J Rucker, et al.
The American Journal of Psychiatry
|
November 2, 2019
Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential
Rupert McShane, David S Baldwin, R Hamish McAllister-Williams, et al.
The Medical Journal of Australia
|
August 4, 2009
Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
Louisa Degenhardt, Briony K Larance, James R Bell, et al.
LGBT Health
|
July 25, 2022
Differences in Alcohol and Other Drug Use and Dependence Between Transgender and Cisgender Participants from the 2018 Global Drug Survey
Dean J Connolly, Emma Davies, Michael Lynskey, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Substance Abuse : Research and Treatment
|
September 20, 2017
Moving on From Representativeness: Testing the Utility of the Global Drug Survey
Monica J Barratt, Jason A Ferris, Renee Zahnow, et al.
Drug and Alcohol Review
|
March 30, 2022
Who uses digital drugs? An international survey of 'binaural beat' consumers
Monica J Barratt, Alexia Maddox, Naomi Smith, et al.
Journal of Psychopharmacology (Oxford, England)
|
March 6, 2023
Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason A Ferris, Adam R Winstock, et al.
Drug and Alcohol Dependence
|
January 9, 2022
Exploring Televend, an innovative combination of cryptomarket and messaging app technologies for trading prohibited drugs
Monica J Barratt, Francois R Lamy, Liam Engel, et al.
International Journal of Public Health
|
April 2, 2018
Do people with intersecting identities report more high-risk alcohol use and lifetime substance use?
Daniel Demant, Oscar Oviedo-Trespalacios, Julie-Anne Carroll, et al.
Psychopharmacology
|
September 17, 2021
Clinical withdrawal symptom profile of synthetic cannabinoid receptor agonists and comparison of effects with high potency cannabis
Sam Craft, Jason A Ferris, Monica J Barratt, et al.
Journal of Psychopharmacology (Oxford, England)
|
June 8, 2022
Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
Emma I Kopra, Jason A Ferris, James J Rucker, et al.
The American Journal of Psychiatry
|
November 2, 2019
Esketamine and the Need for a New Type of Registry for Drugs With Abuse Potential
Rupert McShane, David S Baldwin, R Hamish McAllister-Williams, et al.
The Medical Journal of Australia
|
August 4, 2009
Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation
Louisa Degenhardt, Briony K Larance, James R Bell, et al.
LGBT Health
|
July 25, 2022
Differences in Alcohol and Other Drug Use and Dependence Between Transgender and Cisgender Participants from the 2018 Global Drug Survey
Dean J Connolly, Emma Davies, Michael Lynskey, et al.
Page
of 9